Aurora Cannabis in talks to acquire MedReleaf

By zaymalz malz

Leading Canadian cannabis company Aurora Cannabis has confirmed market speculation that it has been engaged in potential takeover talks with fellow industry operator MedReleaf.

“The Company does confirm that it engages in discussions with industry participants from time to time, including MedReleaf,” Aurora Cannabis stated. “At this time the Company confirms there is no agreement, understanding or arrangement with respect to any transaction with MedReleaf.”

See also:

The speculation came as the Investment Industry Regulatory Organization of Canada halted trading in shares of both MedReleaf Corp and Aurora Cannabis, “pending news”.

“The Company has not entered into an agreement to effect any particular transaction, and there can be no assurance that such discussions will result in any such agreement,” MedReleaf confirms.

A successful acquisition would not come as much of a surprise, with Aurora Cannabis having become the world’s largest cannabis company after it closed the acquisition of CanniMed in a $1.1bn deal – an agreement that was first revealed in January of this year.


Featured Articles

JPMorgan Chase: Committed to supporting the next generation

JPMorgan has unveiled a host of new and expanded philanthropic activities totalling US$3.5 million to support the development of apprenticeship programmes

How efficient digital ecosystems became business critical

During this unprecedented era of rapid digital transformation, establishing a well-functioning ecosystem stands to benefit both employees and customers

Mastercard: Supporting clients at a time of rapid evolution

Mastercard has announced a significant expansion of its consulting business with the launch of new practices dedicated to both AI and economics

Why Ceridian has boldly rebranded to Dayforce

Human Capital

McKinsey’s eight lessons in leadership for aspiring CEOs

Leadership & Strategy

KPMG: The biggest challenges facing global CEOs in 2023

Leadership & Strategy